Why the study?
Does the HAS-BLED score accurately assess the 1-year risk of major bleeding in patients with atrial fibrillation?
Does the HAS-BLED score accurately assess the 1-year risk of major bleeding in patients with atrial fibrillation?
The novel HAS-BLED score provides a practical tool to assess individual 1-year major bleeding risk in real-world patients with atrial fibrillation, supporting clinical decision-making for antithrombotic therapy.
No takes yet. Share an insight, caveat, or question.
May aid AF bleeding risk assessment; leaves open need for prospective validation before practice change.
Pisters et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: